Literature DB >> 20089532

DJ-1 deficient mice demonstrate similar vulnerability to pathogenic Ala53Thr human alpha-syn toxicity.

Chenere P Ramsey1, Elpida Tsika, Harry Ischiropoulos, Benoit I Giasson.   

Abstract

Parkinson's disease (PD) is the most common neurodegenerative movement disorder. A pathological hallmark of PD is the presence of intraneuronal inclusions composed of fibrillized alpha-synuclein (alpha-syn) in affected brain regions. Mutations in the gene, PARK7, which encodes DJ-1, can cause autosomal recessive early-onset PD. Although DJ-1 has been shown to be involved in diverse biological processes, several in vitro studies suggest that it can inhibit the formation and protect against the effects of alpha-syn aggregation. We previously established and characterized transgenic mice expressing pathogenic Ala53Thr human alpha-syn (M83 mice) that develop extensive alpha-syn pathologies in the neuroaxis resulting in severe motor impairments and eventual fatality. In the current study, we have crossbred M83 mice on a DJ-1 null background (M83-DJnull mice) in efforts to determine the effects of the lack of DJ-1 in these mice. Animals were assessed and compared for survival rate, distribution of alpha-syn inclusions, biochemical properties of alpha-syn protein, demise and function of nigral dopaminergic neurons, and extent of gliosis in the neuroaxis. M83 and M83-DJnull mice displayed a similar onset of disease and pathological changes, and none of the analyses to assess for changes in pathogenesis revealed any significant differences between M83 and M83-DJnull mice. These findings suggest that DJ-1 may not function to directly modulate alpha-syn nor does DJ-1 appear to play a role in protecting against the deleterious effects of expressing pathogenic Ala53Thr alpha-syn in vivo. It is possible that alpha-syn and DJ-1 mutations may lead to PD via independent mechanisms.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20089532      PMCID: PMC2846158          DOI: 10.1093/hmg/ddq017

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  106 in total

1.  Parkinsonism: onset, progression and mortality.

Authors:  M M Hoehn; M D Yahr
Journal:  Neurology       Date:  1967-05       Impact factor: 9.910

2.  Human alpha-synuclein over-expression increases intracellular reactive oxygen species levels and susceptibility to dopamine.

Authors:  Eunsung Junn; M Maral Mouradian
Journal:  Neurosci Lett       Date:  2002-03-08       Impact factor: 3.046

Review 3.  Synucleinopathies: clinical and pathological implications.

Authors:  J E Galvin; V M Lee; J Q Trojanowski
Journal:  Arch Neurol       Date:  2001-02

4.  PARK7 DJ-1 protects against degeneration of nigral dopaminergic neurons in Parkinson's disease rat model.

Authors:  Masatoshi Inden; Takahiro Taira; Yoshihisa Kitamura; Takashi Yanagida; Daiju Tsuchiya; Kazuyuki Takata; Daijiro Yanagisawa; Kaneyasu Nishimura; Takashi Taniguchi; Yoshiaki Kiso; Kanji Yoshimoto; Tomohiro Agatsuma; Shizuyo Koide-Yoshida; Sanae M M Iguchi-Ariga; Shun Shimohama; Hiroyoshi Ariga
Journal:  Neurobiol Dis       Date:  2006-07-24       Impact factor: 5.996

5.  DJ-1 gene deletion reveals that DJ-1 is an atypical peroxiredoxin-like peroxidase.

Authors:  Eva Andres-Mateos; Celine Perier; Li Zhang; Beatrice Blanchard-Fillion; Todd M Greco; Bobby Thomas; Han Seok Ko; Masayuki Sasaki; Harry Ischiropoulos; Serge Przedborski; Ted M Dawson; Valina L Dawson
Journal:  Proc Natl Acad Sci U S A       Date:  2007-08-31       Impact factor: 11.205

Review 6.  Molecular mechanisms of alpha-synuclein neurodegeneration.

Authors:  Elisa A Waxman; Benoit I Giasson
Journal:  Biochim Biophys Acta       Date:  2008-10-09

7.  Oxidizable residues mediating protein stability and cytoprotective interaction of DJ-1 with apoptosis signal-regulating kinase 1.

Authors:  Jens Waak; Stephanie S Weber; Karin Görner; Christoph Schall; Hidenori Ichijo; Thilo Stehle; Philipp J Kahle
Journal:  J Biol Chem       Date:  2009-03-16       Impact factor: 5.157

8.  Leucine-Rich Repeat Kinase 2 interacts with Parkin, DJ-1 and PINK-1 in a Drosophila melanogaster model of Parkinson's disease.

Authors:  Katerina Venderova; Ghassan Kabbach; Elizabeth Abdel-Messih; Yi Zhang; Robin J Parks; Yuzuru Imai; Stephan Gehrke; Johnny Ngsee; Matthew J Lavoie; Ruth S Slack; Yong Rao; Zhuohua Zhang; Bingwei Lu; M Emdadul Haque; David S Park
Journal:  Hum Mol Genet       Date:  2009-08-19       Impact factor: 6.150

Review 9.  Emerging pathways in genetic Parkinson's disease: autosomal-recessive genes in Parkinson's disease--a common pathway?

Authors:  Julia C Fitzgerald; Helene Plun-Favreau
Journal:  FEBS J       Date:  2008-12       Impact factor: 5.542

10.  DJ-1 is a redox-dependent molecular chaperone that inhibits alpha-synuclein aggregate formation.

Authors:  Shoshana Shendelman; Alan Jonason; Cecile Martinat; Thomas Leete; Asa Abeliovich
Journal:  PLoS Biol       Date:  2004-10-05       Impact factor: 8.029

View more
  9 in total

Review 1.  The role of cysteine oxidation in DJ-1 function and dysfunction.

Authors:  Mark A Wilson
Journal:  Antioxid Redox Signal       Date:  2011-01-14       Impact factor: 8.401

Review 2.  Genetic animal models of Parkinson's disease.

Authors:  Ted M Dawson; Han Seok Ko; Valina L Dawson
Journal:  Neuron       Date:  2010-06-10       Impact factor: 17.173

3.  YajL, prokaryotic homolog of parkinsonism-associated protein DJ-1, functions as a covalent chaperone for thiol proteome.

Authors:  Hai-Tuong Le; Valérie Gautier; Fatoum Kthiri; Abderrahim Malki; Nadia Messaoudi; Mouadh Mihoub; Ahmed Landoulsi; Young Jun An; Sun-Shin Cha; Gilbert Richarme
Journal:  J Biol Chem       Date:  2011-12-07       Impact factor: 5.157

4.  Progressive dopaminergic cell loss with unilateral-to-bilateral progression in a genetic model of Parkinson disease.

Authors:  Maxime W C Rousseaux; Paul C Marcogliese; Dianbo Qu; Sarah J Hewitt; Sarah Seang; Raymond H Kim; Ruth S Slack; Michael G Schlossmacher; Diane C Lagace; Tak W Mak; David S Park
Journal:  Proc Natl Acad Sci U S A       Date:  2012-09-10       Impact factor: 11.205

Review 5.  Mitochondrial dysfunction in genetic animal models of Parkinson's disease.

Authors:  Alzbeta Trancikova; Elpida Tsika; Darren J Moore
Journal:  Antioxid Redox Signal       Date:  2011-10-04       Impact factor: 8.401

6.  DJ-1 can inhibit microtubule associated protein 1 B formed aggregates.

Authors:  Zhiquan Wang; Yu Zhang; Shi Zhang; Qianqian Guo; Yuyan Tan; Xinyi Wang; Ran Xiong; Jianqing Ding; Shengdi Chen
Journal:  Mol Neurodegener       Date:  2011-06-06       Impact factor: 14.195

7.  Potentiation of neurotoxicity in double-mutant mice with Pink1 ablation and A53T-SNCA overexpression.

Authors:  Suzana Gispert; Nadine Brehm; Jonas Weil; Kay Seidel; Udo Rüb; Beatrice Kern; Michael Walter; Jochen Roeper; Georg Auburger
Journal:  Hum Mol Genet       Date:  2014-10-08       Impact factor: 6.150

8.  Increased vulnerability of nigral dopamine neurons after expansion of their axonal arborization size through D2 dopamine receptor conditional knockout.

Authors:  Nicolas Giguère; Benoît Delignat-Lavaud; Freja Herborg; Aurore Voisin; Yuan Li; Vincent Jacquemet; Madhu Anand-Srivastava; Ulrik Gether; Bruno Giros; Louis-Éric Trudeau
Journal:  PLoS Genet       Date:  2019-08-26       Impact factor: 5.917

9.  DJ-1 (Park7) affects the gut microbiome, metabolites and the development of innate lymphoid cells (ILCs).

Authors:  Yogesh Singh; Christoph Trautwein; Achal Dhariwal; Madhuri S Salker; Md Alauddin; Laimdota Zizmare; Lisann Pelzl; Martina Feger; Jakob Admard; Nicolas Casadei; Michael Föller; Vivek Pachauri; David S Park; Tak W Mak; Julia-Stefanie Frick; Diethelm Wallwiener; Sara Y Brucker; Florian Lang; Olaf Riess
Journal:  Sci Rep       Date:  2020-09-30       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.